Newsarchive 2009

Oct 5, 2009	The city of Tampere rewarded Santen for technical creativity
Apr 15, 2009	Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension
Apr 3, 2009	Personnel Survey 2009: Overall personnel satisfaction improved




Feb 9, 2009	Santen Became the Market Leader in Finland
Jan 20, 2009	Taflotan going strong in Europe
Jan 14, 2009	The Strongest in Finland Certificate granted to Santen